TRIA At-Home Laser Hair Removal Device Cleared by FDA

TRIA is First Entry to Home-Based Device Market Featuring Diode Laser
                       Technology for Hair Removal

   PLEASANTON, Calif., Feb. 7 /PRNewswire/ -- SpectraGenics, a leader in
light-based therapeutic beauty devices, today announced over-the-counter
(OTC) clearance from the United States Food and Drug Administration (FDA)
for their patented hand-held laser hair removal device designed for at-home
use. The TRIA is the first hair removal laser to enter the U.S. home-based
device market, an industry projected to grow exponentially over the next
three years.

   "The FDA clearance is the culmination of many years of research,
clinical testing and innovative product design efforts," said Robert Grove,
PhD, CEO, SpectraGenics. "Our engineers are the same scientists who
developed the first and gold-standard professional diode laser hair removal
system over 10 years ago which is still used by physicians nationwide.
We've invested significant resources to harness that same light-based
technology to deliver a safe, effective way for consumers to treat unwanted
hair in the privacy of their homes."

   The TRIA device is the first at-home device to feature a diode laser
specially designed to be safe and effective for at-home use. SpectraGenics
has been selling a version of the TRIA, called i-Epi, in Japan since 2005.
The TRIA is the first in a series of at-home science-based beauty devices
to be pioneered by SpectraGenics.

   "I have been performing laser hair removal in my office for 12 years
and welcome the arrival of TRIA as an adjunct to professional laser hair
removal," said Eric F. Bernstein, MD, Clinical Associate Professor at the
University of Pennsylvania. "TRIA is simple, safe and very effective. Many
of my patients will be able to use TRIA for touch-ups in between visits as
well as on other areas not treated in-office to achieve and maintain
beautiful results, and I expect it to increase the number of patients I see
for laser hair removal. The TRIA was developed by the engineers who created
the diode hair removal laser I use in my office today."

   Professional laser hair removal is consistently the leading
non-surgical cosmetic treatment for women 34 years and under, and the
second most popular procedure for women over 35, according to the American
Society for Aesthetic Plastic Surgery. The at-home device market is
relatively new and expected to grow exponentially with the introduction of
products targeted for treatment of hair, acne, wrinkles and skin
rejuvenation.

   TRIA will be available Spring 2008 from medical professionals and
select retailers, as well as online at http://www.triabeauty.com.

   SpectraGenics, Inc., the leader in light-based therapeutic beauty
devices, gives men and women the freedom to incorporate clinically-proven
aesthetic technologies into their personal care regimen. In 1993 Robert
Grove, Ph.D., and a team of American dermatologists and engineers developed
the first diode laser for hair removal utilized by physicians in their
medical practices. In 2003, these individuals founded SpectraGenics, Inc.
and assembled an internationally renowned team of experts in the field of
aesthetic lasers to begin the development of its flagship TRIA device and
future innovations in science-driven consumer beauty products.